Traykov Vassil, Puererfellner Helmut, Burri Haran, Foldesi Csaba Laszlo, Scherr Daniel, Duncker David, Arbelo Elena, Botto Giovanni Luca, Boriani Giuseppe, Heidbuchel Hein, Malaczynska-Rajpold Katarzyna, Farkowski Michal M, Dagres Nikolaos, Szymanski Piotr, Huculeci Radu, Casado-Arroyo Ruben, Boveda Serge, Merino José L
Department of Invasive Electrophysiology, Acibadem City Clinic Tokuda University Hospital, Sofia, Bulgaria.
Department of Cardiology, Ordensklinikum Linz Elisabethinen, Linz, Austria.
Europace. 2025 Aug 4;27(8). doi: 10.1093/europace/euaf149.
The 2024 European Heart Rhythm Association (EHRA) Summit in Warsaw focused on the digital transformation of arrhythmia management, convening over 130 stakeholders from academia, industry, and policy. This review summarises the current state (in 2025) and future directions of digital health in arrhythmia care, including remote monitoring (RM) of cardiac implantable electronic devices (CIEDs), mobile health (mHealth), artificial intelligence (AI), and integration into the European Health Data Space (EHDS). RM has become central to CIED follow-up, improving outcomes and reducing healthcare use. However, challenges in reimbursement, workforce adaptation, and data interoperability persist. The absence of standardised data exchange between device vendors and healthcare systems has led to initiatives like the World Forum on CIED follow-up to develop interoperability standards. mHealth tools, including apps and wearable devices, offer accurate arrhythmia detection but face regulatory, digital literacy, and privacy barriers. The EHDS aims to enable cross-border data sharing for personalised care and real-world research, though implementation must address ethical, legal, and infrastructural issues. AI shows promise in prediction, monitoring, and data integration, but lacks standardised, transparent validation. The ESC-EHRA Atlas in Heart Rhythm Disorders supports structured data collection to harmonize and benchmark care across Europe. Overall, digital innovations, if coupled with regulatory alignment, interoperability standards, and equitable access, have the potential to shift arrhythmia management toward a more predictive, personalized, and efficient model of care.
2024年在华沙举行的欧洲心律协会(EHRA)峰会聚焦于心律失常管理的数字化转型,召集了来自学术界、行业和政策领域的130多名利益相关者。本综述总结了心律失常护理中数字健康的当前状况(2025年)和未来方向,包括心脏植入式电子设备(CIED)的远程监测(RM)、移动健康(mHealth)、人工智能(AI)以及融入欧洲健康数据空间(EHDS)。RM已成为CIED随访的核心,改善了治疗结果并减少了医疗保健的使用。然而,报销、劳动力适应和数据互操作性方面的挑战依然存在。设备供应商与医疗保健系统之间缺乏标准化的数据交换,导致了诸如CIED随访世界论坛等倡议,以制定互操作性标准。mHealth工具,包括应用程序和可穿戴设备,可提供准确的心律失常检测,但面临监管、数字素养和隐私障碍。EHDS旨在实现跨境数据共享,以提供个性化护理和开展真实世界研究,不过实施过程必须解决伦理、法律和基础设施问题。AI在预测、监测和数据整合方面显示出前景,但缺乏标准化、透明的验证。《欧洲心脏病学会 - 欧洲心律协会心律失常疾病图谱》支持结构化数据收集,以协调和规范全欧洲的护理。总体而言,如果数字创新与监管协调、互操作性标准和公平获取相结合,就有可能将心律失常管理转向更具预测性、个性化和高效的护理模式。